17.4 Quality Improvement (ESRD QIP), Ethics & Palliative Care

Quality Improvement (ESRD QIP), Ethics & Palliative Care

Maintenance hemodialysis is an intensive, technology-dependent life-sustaining therapy. Delivering optimal nephrology care requires integrating continuous clinical quality improvement, federal value-based purchasing mandates, professional bioethics, and compassionate palliative support. Certified Hemodialysis Nurses play a decisive role in evaluating clinical metrics, conducting root-cause analyses, upholding patient autonomy, and guiding compassionate end-of-life care.

---

Quality Assessment and Performance Improvement (QAPI) (§ 494.180)

Federal regulations under 42 CFR §494.110 mandate that every Medicare-certified dialysis facility maintain an active, facility-wide, data-driven Quality Assessment and Performance Improvement (QAPI) program:

• Interdisciplinary Governance: The QAPI committee includes the Medical Director, Clinical Nurse Manager, Staff RNs, Renal Dietitian, Nephrology Social Worker, and Chief Technician. The committee meets at least monthly to analyze clinical data and operational trends.
• Core Clinical Indicators Tracked:
  • Hemodialysis adequacy ($spKt/V$, $URR$).
  • Vascular access outcomes (AVF prevalence, catheter rates, thrombosis, stenosis).
  • Anemia management (hemoglobin distribution, ESA dosing, iron indices).
  • Mineral and bone disorder parameters (calcium, phosphorus, PTH).
  • Infection control metrics (catheter-related bloodstream infections [CRBSI], access infections, hospitalization rates).
  • Water treatment quality logs (chlorine tests, colony counts, endotoxin assays).
  • Patient satisfaction and grievances.
• Continuous Quality Improvement (CQI) Methodologies:
  • When clinical metrics fall below established thresholds, the facility initiates a structured improvement process using the Plan-Do-Study-Act (PDSA) cycle.
  • Root Cause Analysis (RCA): Used to investigate serious adverse events (such as dialyzer blood leaks, catastrophic circuit disconnections, severe medication errors, or clusters of bacteremia). The team utilizes tools such as the "Five Whys" and Ishikawa (fishbone) diagrams to identify systemic latent vulnerabilities rather than focusing on individual blame.

---

CMS ESRD Quality Incentive Program

QIP links Medicare dialysis payment to facility performance, with reductions up to 2%. Distinguish a payment year’s finalized measure specifications from a proposed future rule, and distinguish regulatory measurement from an individual patient’s treatment order. A facility’s total performance score is calculated from applicable measures, eligibility rules and achievement/improvement methods; it is not a simple penalty whenever one patient crosses a threshold.

CMS removed the ultrafiltration-rate reporting measure and standardized fistula-rate clinical measure beginning with payment year 2026. Therefore, neither a claimed 80% fistula mandate nor a universal 13-mL/kg/hour QIP penalty describes current QIP. Clinical attention to access infection and rapid fluid removal remains appropriate even when a measure is removed.

For payment years 2027–2028, finalized domains include adequacy and long-term catheter rate in clinical care; hospitalization, readmission, waitlisting and depression follow-up in care coordination; NHSN bloodstream infection in safety; ICH-CAHPS patient experience; and reporting measures such as hypercalcemia and medication reconciliation. Hypercalcemia has been a reporting measure since payment year 2025, not the old clinical penalty described in older teaching. Check the specific payment-year technical document for exclusions, scoring and thresholds rather than memorizing a universal catheter percentage penalty.

QAPI in Practice

A PDSA cycle defines a measurable change, tests it, studies results and adapts. A bloodstream-infection rate requires the correct denominator and definition; comparing raw counts from units of different size can mislead. Root-cause analysis preserves event evidence and examines latent system problems alongside individual actions. Training alone will not solve a mislabeled supply process or an alarm configuration defect.

Bioethics in Nephrology Nursing Practice

Hemodialysis practice involves complex bioethical decisions balancing technical intervention against patient suffering. Nephrology nurses adhere to the BONENT Code of Ethics and ANNA Standards of Practice, grounded in four foundational bioethical principles:

• Autonomy: Respecting the patient's right to self-determination. Patients have the legal and ethical right to make informed choices regarding their health, select between dialysis modalities (hemodialysis vs. peritoneal dialysis vs. home therapy), refuse specific interventions (such as blood transfusions or cannulation attempts), and make the decision to discontinue dialysis entirely. Informed consent requires clear disclosure of risks, benefits, and alternatives.
• Beneficence: The moral obligation to act in the best interest of the patient. Nurses demonstrate beneficence by delivering meticulous care, optimizing dialysis adequacy, advocating for timely access creation, and promoting physical and psychosocial rehabilitation.
• Non-Maleficence: The duty to "do no harm." In hemodialysis, this translates into avoiding rapid fluid extraction ($UFR > 13\text{ mL/kg/hr}$), strictly adhering to aseptic technique during line connections to prevent life-threatening bacteremia, preventing vascular access trauma, and ensuring machine safety limits are active.
• Justice: The ethical obligation to treat all patients fairly and equitably. This encompasses non-discriminatory care delivery, equitable distribution of dialysis station shifts, and fair advocacy for kidney organ transplantation regardless of age, race, socioeconomic status, or etiology of renal failure.

---

Advance Care Planning, Conservative Kidney Management & Dialysis Withdrawal

End-stage renal disease is a life-limiting illness with a median survival comparable to many advanced malignancies.

Advance Care Planning (ACP)

Nephrology nurses actively facilitate advance care planning conversations. Key legal instruments include:

• Living Will: Documents specific preferences regarding life-sustaining interventions (mechanical ventilation, cardiopulmonary resuscitation, tube feeding, dialysis continuation).
• Durable Power of Attorney for Healthcare (DPOA-HC): Appoints a designated surrogate decision-maker to articulate the patient's values if the patient loses decision-making capacity.
• POLST/MOLST (Physician/Medical Orders for Life-Sustaining Treatment): Translates patient preferences into actionable, immediately enforceable medical orders across care settings.

Conservative Kidney Management (CKM)

• CKM is a planned, comprehensive, non-dialytic supportive treatment paradigm for advanced CKD/ESRD.
• It is particularly suited for frail, elderly individuals with multiple competing comorbidities (such as severe ischemic cardiomyopathy, advanced dementia, or multi-organ failure) when the possible survival advantage is uncertain or outweighed by the patient’s assessed burdens and goals, increases hospitalization days, and substantially impairs quality of life.
• CKM focuses on active medical management of anemia, fluid overload (judicious loop diuretics), metabolic acidosis, and uremic symptoms without initiating extracorporeal therapy.

Dialysis Discontinuation / Withdrawal

• Voluntary cessation of maintenance dialysis is common, accounting for $20\%\text{ to }25\%$ of all ESRD deaths in the United States.
• Competent patients—or their designated legal surrogates when the patient lacks capacity—have the absolute ethical and legal right to withdraw from maintenance dialysis.
• Clinical Role of the Certified Hemodialysis Nurse:
  • Validate the patient's decision, ensuring it is informed, voluntary, and not driven by untreated, reversible depression or inadequate pain control.
  • Coordinate immediate referral to hospice and palliative care for in-home or inpatient hospice management. Medication selection and dose require renal/palliative expertise. Morphine and codeine metabolites are problematic in kidney failure; hydromorphone also requires caution, and methadone needs specialist experience.
• Food and fluid: Use an individualized comfort-focused plan balancing thirst, preferences and congestion rather than imposing rigid restrictions against the patient’s goals.
• Survival after withdrawal varies with residual function, intake and illness. Discuss uncertainty, prepare for symptoms and provide ongoing support; do not promise a fixed interval or symptom-free death.

Palliative care supports comfort and goals whether dialysis continues or stops. Withdrawal survival varies with residual kidney function, intake and comorbidity; a 7–14-day estimate is not a promise. Evaluate decision-making capacity, reversible distress and the patient’s values without coercion. Hospice eligibility and coverage depend on the actual circumstances, so referral is evaluated rather than guaranteed for everyone. Opioid choice and dosing require renal/palliative expertise: hydromorphone metabolites can still accumulate, and methadone requires specialist experience. Comfort-focused eating and drinking balances thirst and congestion rather than imposing rigid restrictions against a dying patient’s wishes.

Sources checked 2026-10-10: CMS QIP specifications